Plasma levels of nelfinavir, which is metabolised predominantly by CYP2C19 and only partially by CYP3A4, are not greatly increased by co-administration with ritonavir, and therefore co-administration of nelfinavir with low-dose ritonavir does not appear to be beneficial.